Research Article Volume 18 Issue 11 - 2026

Choline and Ginkgo biloba Supplementation in Adults with Asthenia
and Cognitive Impairment: A Prospective Open-Label Study

Vasily V Afanasiev1*, E L Pugacheva2, N F Porkhun2, N V Petrova1 and S A Klimantsev1

1Department of Emergency Medicine, I. I. Mechnikov North-Western State Medical University, Ministry of Health of the Russian Federation, St. Petersburg, Russia
2Department of Neurology, Pavlov First Saint Petersburg State Medical University, Ministry of Health of the Russian Federation, St. Petersburg, Russia

*Corresponding Author: Vasily V Afanasiev, Department of Emergency Medicine, I. I. Mechnikov North-Western State Medical University, Ministry of Health of the Russian Federation, St. Petersburg, Russia.
Received: October 26, 2026; Published: November 16, 2026



Asthenia commonly coexists with cognitive impairment, anxiety, depressive symptoms, and sleep disturbances. Serotonergic systems modulate cholinergic activity, providing a rationale for investigating choline and Ginkgo biloba supplementation. This study evaluated changes in asthenic symptoms, cognition, and associated manifestations during supplementation. A prospective, open- label study included 44 adults aged 45-65 years, including 20 healthy controls; patients had asthenia and mild to moderate cognitive impairment. Choline Strong, containing choline 550 mg and standardized Ginkgo biloba 60 mg per capsule, was administered as one capsule twice daily for 60 days. Assessments were performed at baseline and on Days 30 and 60 using the Asthenic State Scale, Multidimensional Fatigue Inventory (MFI-20), Montreal Cognitive Assessment (MoCA), Schulte tables test, Spielberger anxiety inventory, Beck Depression Inventory, and sleep quality questionnaire. Changes across cognitive, emotional, and fatigue-related domains were evaluated to characterize the pattern and time course of clinical responses. Healthy controls provided reference values. Results were expressed as mean ± standard error. By Day 60, Asthenic State Scale scores decreased from 90.3 ± 5.2 to 55.2 ± 0.8, while MoCA scores increased from 25.4 ± 0.5 to 29.2 ± 0.1 (both p ≤ 0.01 versus baseline). Schulte test completion time decreased from 181.3 ± 8.2 to 50.9 ± 5.6 seconds (p ≤ 0.01). State anxiety scores decreased from 59.3 ± 2.0 to 30.2 ± 1.7, and depression scores decreased from 15.3 ± 0.8 to 9.7 ± 0.8. Sleep quality scores increased from 16.7 ± 1.2 to 20.8 ± 0.6. General, physical, and mental fatigue also improved, with changes evident by Day 30. No adverse events or treatment discontinuations were reported. Supplementation was associated with improvements in asthenia, cognition, and associated symptoms over 60 days. The open-label design and absence of a defined placebo comparator limit causal interpretation. Randomized, placebo-controlled studies are needed to confirm these findings.

Keywords: Asthenia; Cognitive Dysfunction; Depression; Choline Strong; Choline; Ginkgo biloba; Receptors; Asthenia Assessment Scales

  1. Denisenko PP. “The role of cholinergic systems in regulatory processes”. Moscow: Med (1980): 296.
  2. Kendell E., et al. “Principles of neural science”. 4th McGraw-Hill (2000): 1750.
  3. Pollack A. “Anatomy, Physiology, and Pharmacology of the Basal Ganglia”. Neurologic Clinics3 (2001): 523-534. 
  4. Afanasiev VV., et al. “Pharmacology and Clinical Use of Cholinergic Agents: A Guide for Physicians”. St. Petersburg: Iskusstvo Rossii (2011): 357.
  5. Minutko VL. “Biomarker Strategies for Dopaminergic Therapy”. Minutko Clinic LLC (April 20, 2022).
  6. Adell A., et al. “Serotonin Interaction with Other Transmitter Systems”. In: Müller, editor. Handbook of Behavioral Neuroscience 21 (2010): 259-276. 
  7. Carruthers S., et al. “Melmon and Morrelli's Clinical Pharmacology”. 4th McGraw-Hill Medical (2000): 1433.
  8. Siegel G., et al. “Basic Neurochemistry: Molecular, Cellular and Medical Aspects”. 6th Lippincott-Raven (1999).
  9. Del Arco A., et al. “Prefrontal Stimulation of GABA-A Receptors Counteracts the Corticolimbic Hyperactivity Produced by NMDA Antagonists in the Prefrontal Cortex of the Rat”. Psychopharmacology2 (2011): 525-536. 
  10. Brink TC., et al. “Activation of the Immune Response Is a Key Feature of Aging in Mice”. Biogerontology6 (2009): 721-734. 
  11. Afanasiev VV. “Alcohol Withdrawal Syndrome”. St. Petersburg: Intermedika (2002): 346.
  12. Li X., et al. “Generation of a Whole-Brain Atlas for the Cholinergic System and Mesoscopic Projectome Analysis of Basal Forebrain Cholinergic Neurons”. Proceedings of the National Academy of Sciences of the United States of America2 (2018): 415-420. 
  13. Lobzin SG., et al. “Effects of Dysfunction of the Brain Cholinergic System on Cognitive Function: A Literature Review”. Herald of the North-Western State Medical University Named After I. I. Mechnikov4 (2017): 53-58.
  14. Bush G., et al. “Cognitive and Emotional Influences in Anterior Cingulate Cortex”. Trends in Cognitive Sciences6 (2000): 215-222. 
  15. Carter R. “The Human Brain: An Illustrated Guide to Its Structure, Function, and Disorders”. Moscow (2019): 266.
  16. , et al. “Hubs and Spokes of the Lateral Hypothalamus: Cell Types, Circuits and Behaviour”. The Journal of Physiology 594.22 (2016): 6443-6462. 
  17. David D., et al. “Why Cognitive Behavioral Therapy Is the Current Gold Standard of Psychotherapy”. Frontiers in Psychiatry 9 (2018): 4. 
  18. Mosher CP., et al. “Neurons in the Monkey Amygdala Detect Eye Contact During Naturalistic Social Interactions”. Current Biology20 (2014): 2459-2464. 
  19. Etkin A and Wager T. “Functional Neuroimaging of Anxiety: A Meta-Analysis of Emotional Processing in PTSD, Social Anxiety Disorder, and Specific Phobia”. American Journal of Psychiatry10 (2007): 1476-1488. 
  20. Volf NV. “An Electrophysiological Study of Cholinergic Mechanisms in the Amygdaloid Complex”. Dissertation abstract for the degree of Candidate of Biological Sciences, specialty 102. Sverdlovsk: Sverdlovsk State Medical Institute (1972): 17.
  21. Fuxe K., et al. “Extrasynaptic Neurotransmission in the Modulation of Brain Function: Focus on the Striatal Neuronal-Glial Networks”. Frontiers in Physiology 3 (2012): 136. 
  22. Normile G and Altman H. “Serotonin Influences on Cholinergic Function: Possible Interactions in Learning and Memory”. In: Levin ED, Decker MW and Butcher LL, editors. Neurotransmitter Interactions and Cognitive Function. Boston: Birkhäuser (1992): 207-227.
  23. Natochin Yu V. “The Anniversary of Academician RAN Yuri Viktorovich Natochin”. I M Sechenov Russian Physiological Journal12 (2022): 1555-1558.

Vasily V Afanasiev., et al. “Choline and Ginkgo biloba Supplementation in Adults with Asthenia and Cognitive Impairment: A Pro- spective Open-Label Study”. EC Neurology 18.11 (2026): 01-14.